European Heart Journal - Cardiovascular Pharmacotherapy : Impact Factor & More
eISSN: 2055-6845pISSN: 2055-6837
Share this on:
Key Metrics
CiteScore 
7.8
H-Index
35
Impact Factor
5 - 10
SJR
Q1Pharmacology (medical)
SNIP
1.61
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on European Heart Journal - Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European Heart Journal - Cardiovascular Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Heart Journal - Cardiovascular Pharmacotherapy
Why does research integrity affect us all?
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Correction to: Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Innovation and constraints in cardiovascular pharmacotherapy.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Why does research integrity affect us all?
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Correction to: Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Response to SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Innovation and constraints in cardiovascular pharmacotherapy.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
SGLT2 inhibitors in heart failure with tricuspid regurgitation: clinical interpretation and future directions.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
Cardiovascular pharmacotherapy in 2025.
- 19 May 2026
- European heart journal. Cardiovascular pharmacotherapy
FAQs on European Heart Journal - Cardiovascular Pharmacotherapy
How long has European Heart Journal - Cardiovascular Pharmacotherapy been actively publishing? 
What is the publishing frequency of European Heart Journal - Cardiovascular Pharmacotherapy?
How many articles did European Heart Journal - Cardiovascular Pharmacotherapy publish last year?
What is the eISSN & pISSN for European Heart Journal - Cardiovascular Pharmacotherapy?
What is Citescore for European Heart Journal - Cardiovascular Pharmacotherapy?
What is the H Index for European Heart Journal - Cardiovascular Pharmacotherapy ?
What is SNIP score for European Heart Journal - Cardiovascular Pharmacotherapy?
What is the SJR for European Heart Journal - Cardiovascular Pharmacotherapy?
Who is the publisher of European Heart Journal - Cardiovascular Pharmacotherapy?
